{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T02:46:35Z","timestamp":1725504395646},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T00:00:00Z","timestamp":1313366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s13312-012-0006-8","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T07:15:11Z","timestamp":1327994111000},"page":"47-49","source":"Crossref","is-referenced-by-count":4,"title":["Ibuprofen Lysinate and sodium ibuprofen for prophylaxis of patent ductus arteriosus in preterm neonates"],"prefix":"10.1007","volume":"49","author":[{"given":"Maria Pia","family":"De Carolis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bersani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,15]]},"reference":[{"key":"6_CR1","doi-asserted-by":"crossref","unstructured":"Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2006;1:CD004213.","DOI":"10.1002\/14651858.CD004213.pub2"},{"key":"6_CR2","doi-asserted-by":"crossref","unstructured":"Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants. Cochrane Database of Syst Rev. 2010;4:CD003481.","DOI":"10.1002\/14651858.CD003481.pub4"},{"key":"6_CR3","unstructured":"Bersani I, De Carolis MP, Lacerenza S, De Rosa G, Fusco FP, Cota F, et al. Is the prophylaxis of patent ductus arteriosus useful in extremely premature infants? Turk J Pediatr. [in press]."},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(04)17477-1","volume":"364","author":"B. Overmeire Van","year":"2004","unstructured":"Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluw\u00e9 W, Jespers A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:1945\u20131949.","journal-title":"Lancet."},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/S0140-6736(04)17476-X","volume":"364","author":"V. Gournay","year":"2004","unstructured":"Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:1939\u20131944.","journal-title":"Lancet."},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1542\/peds.2004-1178","volume":"115","author":"C. Dani","year":"2005","unstructured":"Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: A multicenter, randomized study. Pediatrics. 2005;115:1529\u20131535.","journal-title":"Pediatrics."},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.1996.03530310045031","volume":"275","author":"A. Varvarigou","year":"1996","unstructured":"Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA. 1996;275:539\u2013544.","journal-title":"JAMA."},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1651-2227.2000.tb00767.x","volume":"89","author":"C. Dani","year":"2000","unstructured":"Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V, et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Pediatrica. 2000;89:1369\u20131374.","journal-title":"Acta Pediatrica."},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s004310051288","volume":"159","author":"M.P. Carolis De","year":"2000","unstructured":"De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Ped. 2000;159:364\u2013368.","journal-title":"Eur J Ped."},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00044011-200424120-00005","volume":"24","author":"D. Chassard","year":"2004","unstructured":"Chassard D, Geneteau A, Gualano V, Brault M. Bioequivalence study of two ibuprofen formulations administered intravenously in healthy male volunteers. Clin Drug Investig. 2004;24:739\u2013747.","journal-title":"Clin Drug Investig."},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03118.x","volume":"65","author":"D. Hirt","year":"2008","unstructured":"Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol. 2008;65:629\u2013636.","journal-title":"Br J Clin Pharmacol."},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"e1256","DOI":"10.1542\/peds.2008-1780","volume":"122","author":"A. Cherif","year":"2008","unstructured":"Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara MB, Guellouze N, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics. 2008;122:e1256\u20131261.","journal-title":"Pediatrics"},{"key":"6_CR13","first-page":"85","volume":"20","author":"G. Poon","year":"2007","unstructured":"Poon G. Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus. Proc (Bayl Univ Med Cent) 2007:20;85\u201385.","journal-title":"Proc (Bayl Univ Med Cent)"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-012-0006-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-012-0006-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-012-0006-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T02:18:51Z","timestamp":1561256331000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-012-0006-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,15]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s13312-012-0006-8","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,15]]}}}